Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 dysregulation in lungs of fibrosis-resistant BALB/c mice

Laboratory Investigation

Volumn 94, Issue 9, 2014, Pages 1003-1016

  Wong, Steven ^a   Botelho, Fernando M ^a   Rodrigues, Rebecca M ^a   Richards, Carl D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BONE MORPHOGENETIC PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; EXTRACELLULAR MATRIX; FEMALE; LIGANDS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ONCOSTATIN M; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD1 PROTEIN; STAT3 TRANSCRIPTION FACTOR;

EID: 84906837672     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.81     Document Type: Article

References (46)

1. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms oflung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet2012;380:680-688.
2. Todd NW, Luzina IG, Atamas SP. Molecular and cellular mechanisms ofpulmonary fibrosis. Fibrogenesis Tissue Repair 2012;5:11.
3. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J RareDis 2008;38.
4. Ley B, Collard HR, King TE. Clinical course and prediction of survival inidiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431-440.
5. King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet2011;378:1949-1961.
6. Raghu G, Masta S, Meyers D, et al. Collagen synthesis by normal andfibrotic human lung fibroblasts and the effect of transforming growthfactor-beta. Am Rev Respir Dis 1989;140:95-100.
7. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelialmesenchymaltransition in alveolar epithelial cells by transforminggrowth factor-beta1: Potential role in idiopathic pulmonary fibrosis.Am J Pathol 2005;166:1321-1332.
8. Chapman HA. Epithelial-mesenchymal interactions in pulmonaryfibrosis. Annu Rev Physiol 2011;73:413-435.
9. Cabrera-Beńtez NE, Parotto M, Post M, et al. Mechanical stress induceslung fibrosis by epithelial-mesenchymal transition. Crit Care Med 2012;40:510-517.
10. Kolb M, Bonniaud P, Galt T, et al. Differences in the fibrogenicresponse after transfer of active transforming growth factor-beta1gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mousestrains. Am J Respir Cell Mol Biol 2002;27:141-150.
11. Kim JH, Kim HY, Kim S, et al. Natural killer T (NKT) cells attenuatebleomycin-induced pulmonary fibrosis by producing interferongamma.Am J Pathol 2005;167:1231-1241.
12. Knight DA, Ernst M, Anderson GP, et al. The role of gp130/IL-6cytokines in the development of pulmonary fibrosis: Criticaldeterminants of disease susceptibility and progression? PharmacolTher 2003;99:327-338.
13. Fritz DK, Kerr C, Fattouh R, et al. A mouse model of airway disease:oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, andairway hyperresponsiveness are STAT6 dependent, and interstitialpulmonary fibrosis is STAT6 independent. J Immunol 2011;186:1107-1118.
14. Mozaffarian A, Brewer AW, Trueblood ES, et al. Mechanisms ofoncostatin M-induced pulmonary inflammation and fibrosis.J Immunol 2008;181:7243-7253.
15. Scaffidi AK, Mutsaers SE, Moodley YP, et al. Oncostatin M stimulatesproliferation, induces collagen production and inhibits apoptosis ofhuman lung fibroblasts. Br J Pharmacol 2002;136:793-801.
16. Leach HG, Chrobak I, Han R, et al. Endothelial cells recruitmacrophages and contribute to a fibrotic milieu in Bleomycin lunginjury. Am J Respir Cell Mol Biol 2013;49:1093-1101.
17. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGFbetasignal transduction. J Cell Sci 2001;114(Pt 24):4359-4369.
18. Carbia-Nagashima A, Arzt E. Intracellular proteins and mechanismsinvolved in the control of gp130/JAK/STAT cytokine signaling. IUBMBLife 2004;56:83-88.
19. Fujio Y, Maeda M, Mohri T, et al. Glycoprotein 130 cytokine signal as atherapeutic target against cardiovascular diseases. J Pharmacol Sci2011;117:213-222.
20. O'Donoghue RJJ, Knight DA, Richards CD, et al. Genetic partitioning ofinterleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med 2012;4:939-951.
21. Nagahama KY, Togo S, Holz O, et al. Oncostatin M modulates fibroblastfunction via STAT3. Am J Respir Cell Mol Biol 2013;49:582-591.
22. Yang G, Zhu Z, Wang Y, et al. Bone morphogenetic protein-7 inhibitssilica-induced pulmonary fibrosis in rats. Toxicol Lett 2013;220:103-108.
23. Leppäranta O, Tikkanen JM, Bespalov MM, et al. Bone morphogeneticprotein-inducer tilorone identified by high-throughput screening isantifibrotic in vivo. Am J Respir Cell Mol Biol 2013;48:448-455.
24. Farkas L, Farkas D, Gauldie J, et al. Transient overexpression of Gremlinresults in epithelial activation and reversible fibrosis in rat lungs. Am JRespir Cell Mol Biol 2011;44:870-878.
25. Myllarniemi M, Lindholm P, Ryynanen MJ, et al. Gremlin-mediateddecrease in bone morphogenetic protein signaling promotespulmonary fibrosis. Am J Respir Crit Care Med 2008;177:321-329.
26. Botelho FM, Rangel-Moreno J, Fritz D, et al. Pulmonary expression ofoncostatin M (OSM) promotes inducible BALT formationindependently of IL-6, despite a role for IL-6 in OSM-drivenpulmonary inflammation. J Immunol 2013;191:1453-1464.
27. Fritz DK, Kerr C, Tong L, et al. Oncostatin-M up-regulates VCAM-1 andsynergizes with IL-4 in eotaxin expression: Involvement of STAT6.J Immunol 2006;176:4352-4360.
28. Schust J, Sperl B, Hollis A, et al. Stattic: A small-molecule inhibitor ofSTAT3 activation and dimerization. Chem Biol 2006;13:1235-1242.
29. Volk SW, Wang Y, Mauldin EA, et al. Diminished type III collagenpromotes myofibroblast differentiation and increases scar depositionin cutaneous wound healing. Cells Tissues Organs 2011;194:25-37.
30. Merkel JR, DiPaolo BR, Hallock GG, et al. Type I and type III collagencontent of healing wounds in fetal and adult rats. Proc Soc Exp BiolMed 1988;187:493-497.
31. Ray S, Ju X, Sun H, et al. The IL-6 trans-signaling-STAT3 pathwaymediates ECM and cellular proliferation in fibroblasts from hypertrophicscar. J Invest Dermatol 2013;133:1212-1220.
32. Pechkovsky DV, Prê le CM, Wong J, et al. STAT3-mediated signalingdysregulates lung fibroblast-myofibroblast activation anddifferentiation in UIP/IPF. Am J Pathol 2012;180:1398-1412.
33. Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulatesepithelial cell migration and is required for repair of the bronchiolarepithelium. Am J Pathol 2008;172:1542-1554.
34. Masterson JC, Molloy EL, Gilbert JL, et al. Bone morphogenetic proteinsignalling in airway epithelial cells during regeneration. Cell Signal2011;23:398-406.
35. Pegorier S, Campbell GA, Kay AB, et al. Bone morphogenetic protein(BMP)-4 and BMP-7 regulate differentially transforming growth factor(TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res 2010;11:85.
36. Izumi N, Mizuguchi S, Inagaki Y, et al. BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblaststhrough Id2. Am J Physiol Lung Cell Mol Physiol 2006;290:L120-L126.
37. Pope SM, Zimmermann N, Stringer KF, et al. The eotaxin chemokinesand CCR3 are fundamental regulators of allergen-induced pulmonaryeosinophilia. J Immunol 2005;175:5341-5350.
38. Pope SM, Fulkerson PC, Blanchard C, et al. Identification of a cooperativemechanism involving interleukin-13 and eotaxin-2 in experimentalallergic lung inflammation. J Biol Chem 2005;280:13952-13961.
39. Viola JP, Kiani A, Bozza PT, et al. Regulation of allergic inflammationand eosinophil recruitment in mice lacking the transcription factorNFAT1: Role of interleukin-4 (IL-4) and IL-5. Blood 1998;91:2223-2230.
40. Atochina EN, Beers MF, Tomer Y, et al. Attenuated allergic airwayhyperresponsiveness in C57BL/6 mice is associated with enhancedsurfactant protein (SP)-D production following allergic sensitization.Respir Res 2003;4:15.
41. Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammationin the pathogenesis of idiopathic pulmonary fibrosis. Antioxid RedoxSignal 2008;10:287-301.
42. Abdelaziz MM, Samman YS, Wali SO, et al. Treatment of idiopathicpulmonary fibrosis: Is there anything new? Respirology 2005;10:284-289.
43. Camelo A, Dunmore R, Sleeman MA, et al. The epithelium in idiopathicpulmonary fibrosis: Breaking the barrier. Front Pharmacol 2014;4:173.
44. Nathan N, Thouvenin G, Fauroux B, et al. Interstitial lung disease:physiopathology in the context of lung growth. Paediatr Respir Rev2011;12:216-222.
45. Nightingale J, Patel S, Suzuki N, et al. Oncostatin M, a cytokinereleased by activated mononuclear cells, induces epithelial cellmyofibroblasttransdifferentiation via Jak/Stat pathway activation.J Am Soc Nephrol 2004;15:21-32.
46. Pollack V, Sarközi R, Banki Z, et al. Oncostatin M-induced effects onEMT in human proximal tubular cells: Differential role of ERK signaling.Am J Physiol Renal Physiol 2007;293:F1714-F1726.